TY  - GEN
AU  - Rajala,Hanna L M
AU  - Olson,Thomas
AU  - Clemente,Michael J
AU  - Lagström,Sonja
AU  - Ellonen,Pekka
AU  - Lundan,Tuija
AU  - Hamm,David E
AU  - Zaman,Syed Arshi Uz
AU  - Lopez Marti,Jesus M
AU  - Andersson,Emma I
AU  - Jerez,Andres
AU  - Porkka,Kimmo
AU  - Maciejewski,Jaroslaw P
AU  - Loughran,Thomas P
AU  - Mustjoki,Satu
TI  - The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia
SN  - 1592-8721
PY  - 2015///1015
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Arthritis, Rheumatoid
KW  - genetics
KW  - Biomarkers
KW  - analysis
KW  - Clonal Evolution
KW  - Female
KW  - Follow-Up Studies
KW  - High-Throughput Nucleotide Sequencing
KW  - methods
KW  - Humans
KW  - Killer Cells, Natural
KW  - drug effects
KW  - Leukemia, Large Granular Lymphocytic
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Receptors, Antigen, T-Cell, alpha-beta
KW  - STAT3 Transcription Factor
KW  - T-Lymphocytes
KW  - Young Adult
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.3324/haematol.2014.113142
ER  -